About us

LinkedUp is a group of innovative scientists with a passion for developing visionary new medicines. We believe breakthrough therapies come from genuine science that is data driven.

Our AbLink technology enables us to capture the entire human/animal natural immune repertoire allowing us to deliver a highly diverse panel of functional monoclonal antibodies in a very efficient manner. Our technologies enable us to generate antibodies against challenging targets that have the potential to be translated into therapies with improved efficacy.

Management Team

Greg Li, PhD

Dr. Li is one of our co-founders and has served as our President and Interim Chief Executive Officer and a member of our Board of Directors since the Company’s inception. He has been an integral part of many of our corporate achievements including raising seed financing, business strategy, value creation, operations and R& D engine design. Dr Li worked in various positions in both small biotech and big pharma, with a broad knowledge in both the technical and business sides of the biotech industry.

Stephen D Gillies, PhD

Dr. Gillies is one of our co-founders and has served as our Chief Scientific Officer and as a member of our Board of Directors since the company’s inception. He was the former global oncology research head of Merck KGaA and President of EMD Lexigen between 1999 and 2008. He is a serial entrepreneur and inventor of many protein technologies including immunocytokines, antibody engineering methods, and Fc-fusions. He has created many biologics including two approved drugs, Erbitux and Unituxinand has brought many additional oncology programs into clinical trials.

Advisory Board

Jason Lavinder, Ph.D.

Jason Lavinder is one of our co-founders and was the Vice President of Technical Development. He was in charge of using microfluidic to do single B cell VH-VL native pairing and immune repertoire informatics. He previously worked at Pfizer and at George Georgious’ lab at the University of Texas, Austin and has extensive experience in microfluidics, immune repertoire analysis and antibody discovery. Jason recently returned to his academic position and continues to serve as LinkedUp’s advisor.